Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure
Autor: | Matthew R. Stutz, Nicholas P. Dylla, Steven D. Pearson, Paola Lecompte-Osorio, Ravi Nayak, Maryam Khalid, Emerald Adler, Jaye Boissiere, Huaiying Lin, William Leiter, Jessica Little, Amber Rose, David Moran, Michael W. Mullowney, Krysta S. Wolfe, Christopher Lehmann, Matthew Odenwald, Mark De La Cruz, Mihai Giurcanu, Anne S. Pohlman, Jesse B. Hall, Jean-Luc Chaubard, Anitha Sundararajan, Ashley Sidebottom, John P. Kress, Eric G. Pamer, Bhakti K. Patel |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022) |
Druh dokumentu: | article |
ISSN: | 2041-1723 44035942 |
DOI: | 10.1038/s41467-022-34260-2 |
Popis: | Here, via applying metagenomics and metabolomics analyses, the authors show that fecal microbiota composition and microbiota-derived metabolites predict the trajectory of respiratory function and death in patients with severe SARS-Cov-2 infection, suggesting the gut-lung axis to play an important role in the recovery from COVID-19. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |